Qingfeng Shang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Extracellular vesicles in disease
Papers in
-
- Circular RNAs in diseases 3
- Ubiquitin and proteasome pathways 1
-
- MicroRNA in disease regulation 2
- Cancer-related molecular mechanisms research 2
- Co-authors
- Shengfang Ge (2 shared papers)Renbing Jia (2 shared papers)Zhi Yang (1 shared paper)Yongyun Li (1 shared paper)Huixue Wang (1 shared paper)Christopher W. Gregory (1 shared paper)Deborah A. O’Brien (1 shared paper)Guang Yang (1 shared paper)
- Journals
- Journal of Experimental & Clinical Cancer Research (1 paper)Molecular Cancer (1 paper)Epigenomics (1 paper)PubMed (2 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Qingfeng Shang
5 papers receiving 448 citations
Qingfeng Shang's Hit Papers
Peers
Comparison fields: 5 of 41
- Cancer Research 284
- Molecular Biology 412
- Immunology 18
- Ophthalmology 7
- Pathology and Forensic Medicine 11
Countries citing papers authored by Qingfeng Shang
This map shows the geographic impact of Qingfeng Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng Shang more than expected).
Fields of papers citing papers by Qingfeng Shang
This network shows the impact of papers produced by Qingfeng Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng Shang. The network helps show where Qingfeng Shang may publish in the future.
Co-authors
The 14 scholars most cited alongside Qingfeng Shang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The novel roles of circRNAs in human cancer Hit paper breakdown → | 2019 | 398 |
| 2 | 2019 | 20 | |
| 3 | 2022 | 16 | |
| 4 | Differential expression of CCAAT/enhancer-binding protein-delta (c/EBPdelta) in rat androgen-dependent tissues and human prostate cancer. | 2001 | 14 |
| 5 | [An experimental study of antisense TGF-beta 1 inhibiting keloid fibroblast proliferation in vitro]. | 2001 | 5 |
About Qingfeng Shang
Qingfeng Shang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Infectious Diseases, having authored 5 papers that have together received 453 indexed citations. Recurring topics across this work include Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (2 papers), Cancer-related molecular mechanisms research (2 papers), Estrogen and related hormone effects (1 paper), Ubiquitin and proteasome pathways (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Cancer Research (284 citations), Molecular Biology (412 citations), Immunology (18 citations), Ophthalmology (7 citations) and Pathology and Forensic Medicine (11 citations). Qingfeng Shang has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Shengfang Ge, Renbing Jia, Zhi Yang, Yongyun Li, Huixue Wang, Christopher W. Gregory, Deborah A. O’Brien, Guang Yang, Qian Guo and Xiaowen Wu. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Molecular Cancer, Epigenomics and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.